Harnessing dendritic cells in inflammatory skin diseases
Open Access
- 4 February 2011
- journal article
- review article
- Published by Elsevier BV in Seminars in Immunology
- Vol. 23 (1), 28-41
- https://doi.org/10.1016/j.smim.2011.01.006
Abstract
No abstract availableKeywords
This publication has 181 references indexed in Scilit:
- Identification of TNF-related apoptosis-inducing ligand and other molecules that distinguish inflammatory from resident dendritic cells in patients with psoriasisJournal of Allergy and Clinical Immunology, 2010
- Efficient and versatile manipulation of the peripheral CD4+ T‐cell compartment by antigen targeting to DNGR‐1/CLEC9AEuropean Journal of Immunology, 2010
- Targeting of antigens to skin dendritic cells: possibilities to enhance vaccine efficacyImmunology & Cell Biology, 2010
- Progressive multifocal leukoencephalopathy and other disorders caused by JC virus: clinical features and pathogenesisThe Lancet Neurology, 2010
- Cytokine-Producing Dendritic Cells in the Pathogenesis of Inflammatory Skin DiseasesJournal of Clinical Immunology, 2009
- Resident and “Inflammatory” Dendritic Cells in Human SkinJournal of Investigative Dermatology, 2009
- Functional Specializations of Human Epidermal Langerhans Cells and CD14+ Dermal Dendritic CellsImmunity, 2008
- Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 52-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 2)The Lancet, 2008
- Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 1)The Lancet, 2008
- Targeting TNFα rapidly reduces density of dendritic cells and macrophages in psoriatic plaques with restoration of epidermal keratinocyte differentiationJournal of Dermatological Science, 2007